All resources: Abstracts are open access, presentations and webcasts are reserved to ESMO members
Slides from the courses on Gastric Cancer , Bladder & Kidney , Brain Tumours are open to all!
Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
New! EAU-ESMO Consensus Statements on Bladder Cancer
Find all the latest ESMO Guidelines
and
discover the ESMO Guidelines Slide Sets
!
ESMO Members: Access over 800 webcasts & slides , plus medwireNews
Watch video Highlights or Expert Reports , they are open to all!
11 Dec 2019
Two CAR-T therapy trials and a third study of daratumumab show promise for the treatment of patients with relapsed or treatment-refractory multiple...
10 Dec 2019
The dual-targeted immunotherapy agent mosunetuzumab has induced a durable complete remission in heavily pretreated non-Hodgkin lymphoma patientsESMO...
09 Dec 2019
For patients with treatment-refractory advanced renal cell carcinoma, tivozanib may offer better progression-free survival than sorafenib
06 Dec 2019
Hypertension is more common in chronic lymphocytic leukaemia patients using ibrutinib than expected from clinical trial results
05 Dec 2019
Single-fraction radiation did not meet noninferiority criteria compared against a multifraction approach for maintaining ambulatory status during...
Ulrik Lassen provides an overview of the frequency and distribution of NTRK gene fusions in rare and common human cancers, in particular very high occurrences in some rare cancers where their detection is also a part of diagnostic work-up and a low rate in some frequent cancers. Recent approvals of effective drugs might lead to the change in molecular testing mode: switching from time consuming and costly individual gene fusions detection to NGS.
11-14 Dec 2019, Geneva, Switzerland
29-30 Nov 2019, Lugano, Switzerland
28-29 Nov 2019, Zurich, Switzerland
25-26 Nov 2019, Singapore
22-24 Nov 2019, Singapore, Singapore
20-21 Nov 2019, Singapore
20-21 Nov 2019, Singapore
19-21 Nov 2019, Singapore
15-16 Nov 2019, Lugano, Switzerland
14-17 Nov 2019, Vienna, Austria
14-15 Nov 2019, Lisbon, Portugal
07-09 Nov 2019, London, United Kingdom
25-26 Oct 2019, Valencia, Spain
21-22 Oct 2019, Barcelona, Spain
17-18 Oct 2019, Lugano, Switzerland
